GeneDx holders approve reverse split (1:10-1:50), new shares for $150M offering

GeneDx Holdings Corp.

Reverse stock split authorized at ratio 1:10 to 1:50, exact ratio set by board.
Stock issuance of 22,336,624 shares approved for previously announced $150M offering.
Officer exculpation amendment to charter approved (567M for vs 33M against).
Equity incentive plan share reserve increased by 26M shares (503.9M for vs 97.2M against).
Special meeting vote totals: 599,953,892 for reverse split; 595,937,112 for stock issuance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.